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Background. Bone engineering requires thicker three-dimensional constructs than the maximum thickness supported by standard
cell-culture techniques (2mm). A ﬂow-perfusion bioreactor was developed to provide chemotransportation to thick (6mm)
scaﬀolds. Methods.P o l y u r e t h a n es c a ﬀolds, seeded with murine preosteoblasts, were loaded into a novel bioreactor. Control
scaﬀolds remained in static culture. Samples were harvested at days 2, 4, 6, and 8 and analyzed for cellular distribution, viability,
metabolic activity, and density at the periphery and core. Results. By day 8, static scaﬀolds had a periphery cell density of
67% ± 5.0%, while in the core it was 0.3% ± 0.3%. Flow-perfused scaﬀolds demonstrated peripheral cell density of 94% ± 8.3%
and core density of 76%±3.1% at day 8. Conclusions. Flow perfusion provides chemotransportation to thick scaﬀolds. This system
may permit high throughput study of 3D tissues in vitro and enable prefabrication of biological constructs large enough to solve
clinical problems.
Copyright © 2009 Alexander M. Sailon et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
The replacement of tissue lost through trauma, disease,
or congenital anomalies is a continuing clinical challenge.
Current reconstructive options, including autologous tissue
transfer, allograft, xenograft, and alloplastic implantation,
are limited by donor site morbidity, tissue scarcity, disease
transmission or antigenic incompatibility, hardware infec-
tion, and implant extrusion. Ideally, tissue reconstruction
should avoid sacriﬁcing healthy tissue or using alloplastic
materials by instead engineering autologous replacement
tissue de novo.
Tissue engineers have successfully cultured the cellular
constituents necessary to build a variety of tissue types in
vitro [1]. However, traditional two-dimensional (2D) cell-
culture techniques (e.g., Petri dishes and culture ﬂasks) are
inadequate for three-dimensional (3D) tissue engineering.
In 2D culture, a monolayer of cells is in continuous contact
with culture medium, and simple diﬀusion is suﬃcient to
maintain cell viability [2]. As scaﬀolds gain 3D volume,
however, the central core becomes increasingly separated
from the penumbra of fresh medium; simple diﬀusion
providesinadequateoxygendeliveryandwasteremovalfrom
cells in the core. As a result, only cells in a thin construct
(with a large surface area-to-volume ratio) survive, and
typically only on the peripheral crust of the scaﬀold (up to
2mmdeep)[3]. Nature has addressed this problem in native
bone by establishing a complex lacunocanalicular network
within which a nutrient-rich ﬂuid circulates [4, 5]. Thus,
successful engineering of thick 3D osseous tissue constructs
large enough to solve actual clinical problems will require
novel tissue-engineering strategies that address chemotrans-
portative requirements in their design and implementation.
The last decade has seen numerous attempts at improv-
ing chemotransportation for 3D constructs. For example,
cell-seeded porous scaﬀolds have been set upon orbital
shakers, hung in spinner ﬂasks [6, 7], continuously per-
fused through glass columns [8], or tumbled in rotational
bioreactors [6, 9, 10]. These methods increase medium ﬂuid
ﬂow across the external surface of the scaﬀold, oﬀering
an incremental improvement over traditional static culture
techniques. While these technologies satisfy the external2 Journal of Biomedicine and Biotechnology
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Figure 1: (a) With increased medium ﬂuid ﬂow across the external surface of the scaﬀold, chemotransportation is not guaranteed within
the porous conﬁnes of the scaﬀold interior. (b) Schematic chamber within the ﬂow-perfusion bioreactor. Note that medium is forced to
percolatethroughthescaﬀoldinterior,ensuringchemotransportationtocellswithinthecore.(c)Schematicofthe8-chamberﬂow-perfusion
bioreactor within a standard cell culture incubator. (d) Photograph.
requirement for medium ﬂow, convection of medium at
theexternalsurfacedoesnotguaranteechemotransportation
within the porous conﬁnes of the scaﬀold interior [11].
In fact, the majority of medium in the systems described
above follow the path of least resistance and circumnavigate
the scaﬀold (Figure 1(a))[ 3]. Consequently, convection of
medium alone does not result in penetrating ﬂow that
perfuses the porous construct to provide eﬀective chemo-
transportation.
Amorepromisingideaforeﬀectivechemotransportation
is poroelastic ﬂuid ﬂow [11]. In contrast to technologies like
the spinner ﬂask, we designed a ﬂow-perfusion bioreactor to
address the internal requirement for ﬂow within the porous
network of the scaﬀold (Figures 1(b) and 1(c)). In this
system, porous scaﬀolds are press ﬁt into an experimental
chamber, and medium ﬂows by gravity head or by generated
hydrostatic pressure through the scaﬀold. Because the ﬂuid
path is conﬁned to pass through the scaﬀold—none is
lost to nonperfusing ﬂow—the ﬂow-perfusion bioreactor
promises improved chemotransportation to all regions of a
3D scaﬀold. Furthermore, the ﬂow-perfusion bioreactor is,
in theory, a scalable technology that should support porous
scaﬀolds of any thickness.
Nevertheless, to date, most exogenous tissue-engineering
research has been constrained to using scaﬀolds 2mm in
thickness or less, which are readily sustainable by medium
convection or static culture methods. Therefore, we eval-
uated the eﬃcacy of a novel ﬂow-perfusion bioreactor
in sustaining “thick” 3D scaﬀolds that approach sizes of
clinicalrelevance.Speciﬁcally,asproof ofprinciple, wetested
cylindricalscaﬀoldsmeasuring24mmindiameterand6mm
inthickness.Sincethesescaﬀoldsarethickerthanthe“critical
depth” of 2mm (from core to surface), without eﬀective
ﬂuid ﬂow, they should suﬀer central core necrosis. We
hypothesized that dynamic cell culture with a ﬂow-perfusion
bioreactor will provide adequate chemotransportation to the
coreofathickscaﬀold,thereby,maintainingcellviabilityand
activity.
2.MaterialsandMethods
2.1. Flow-Perfusion Bioreactor Design. The ﬂow-perfusion
bioreactor was machined from solid Teﬂon (SABIC Poly-
mershape; Jacksonville, FL). It contains 8 independent
experimental chambers each measuring 24mm in diameter
and able to accommodate scaﬀolds up to 10mm in thickness
(Figures 1(c) and 1(d)). The ﬂoor of each experimental
chamber is tapered to ensure ﬂow from the outer edges of
the scaﬀold as well as the center to the exit port of the
chamber (Figure 1(b)). Screw caps are ﬁtted with Viton-75
O-rings (McMaster-Carr; Aurora, OH) to ensure a tight seal
andpreventleakage.Thebioreactorrestsuponan8-chamber
medium reservoir, with each experimental chamber directly
overlying its respective medium chamber. The junction
between the bioreactor and reservoir is sealed by a gas-
permeable membrane (Tegaderm; 3M; St. Paul, MN). An 8-
channel peristaltic roller pump (Manostat-Carter; Barnant
Co.; Barrington, IL) draws medium from the reservoir and
administers it to each experimental chamber via 0.89mm ID
platinum-cured silicone tubing (Cole-Parmer; Vernon-Hills,Journal of Biomedicine and Biotechnology 3
IL). Equipment was sterilized by plasma-phase hydrogen
peroxide (Sterrad) processing (bioreactor, screw caps, and
reservoir) and steam autoclave (tubing). The apparatus
was assembled under sterile conditions in a laminar ﬂow
biosafety cabinet. The entire bioreactor was placed in a
standard cell-culture incubator (37◦C, 95% humidiﬁed air,
5% CO2).
2.2. Scaﬀold Design. 24 × 6mm cylindrical polyurethane
scaﬀolds (Biomerix; Somerset, NJ) with an average pore size
of 200μm and 100% pore interconnectivity were used in all
experiments. Scaﬀolds were sterilized by ethylene-oxide gas
sterilization by the manufacturer and sealed in single-use
packets.
2.3. Cell Seeding of Scaﬀolds. MC3T3-E1 murine preosteo-
blas-ticcells(RikenCellBank;Ibaraki,Japan)wereexpanded
by traditional 2D static culture at 37◦C and 5% CO2.
DMEM (Sigma, St. Louis, MO) supplemented with 10%
FBS (Gibco Invitrogen, Carlsbad, CA) was used for this and
all subsequent experiments. At conﬂuence, cells were lifted
using trypsin, resuspended with the same medium, and used
to seed the scaﬀolds. Passage 3–5 cells were used for all
experiments.
Each scaﬀold was placed in a separate well of a 6-
well tissue-culture plate for seeding. Due their hydrophobic
nature, the scaﬀolds were compressed to allow sponge-like
absorption of the cellular suspension upon release of the
compressing force. The scaﬀolds were seeded at a standard
concentration of 4 × 106 cells/cm3 (scaﬀolds processed for
histology 12 hours after seeding conﬁrmed even distribution
of cells throughout the scaﬀold). After seeding, the scaﬀolds
were surrounded by medium (to prevent desiccation) and
placed in the cell-culture incubator overnight to allow
cellular adherence. After 24 hours in static culture, cell-
seeded scaﬀolds were either place in ﬂow-perfusion culture
or continued in static culture.
2.4. Static Culture. For static culture controls, seeded scaf-
folds were maintained in 6-well tissue culture plates with
enough media to cover the scaﬀold in its entirety (10mL).
Medium was changed every other day to remove waste
products of cell metabolism and provide fresh growth sup-
plements (this protocol was selected following optimization
experiments in which static culture of scaﬀolds in larger vol-
umes of media, such as that used in ﬂow-perfusion, without
media changes led to accumulation of waste products and
lack of growth supplements in the vicinity of the scaﬀold),
but otherwise the plates were left undisturbed in the cell-
culture incubator. Scaﬀo l d sw e r eh a r v e s t e da td a y s0 ,2 ,4 ,6 ,
and 8 (n = 3 per time point).
2.5. Dynamic Culture. For dynamic culture, scaﬀolds were
loaded into the bioreactor experimental chambers. Each
reservoir chamber was loaded with 80mL of fresh medium,
which was recycled for the duration of the experiment
(maximum 8 days) at a rate of 1.0mL/min as it entered the
experimental chamber. This rate was suﬃcient to provide
perfusion and permit chemotransportation, but only gen-
erated a ﬂuid shear stress of approximately 0.02dynes/cm2.
This ﬂuid shear stress was intentionally selected in order to
provide subthreshold mechanotransductive stimulation [4].
The ﬂuid ﬂow rate was based upon optimization studies in
which three-dimensional ﬁnite element ﬂuid mechanics and
mass transport models were developed (data not shown).
Scaﬀo l d sw e r eh a r v e s t e da td a y s0 ,2 ,4 ,6 ,a n d8( n = 3p e r
time point).
2.6. Scaﬀold Histology and Analysis. Scaﬀolds from each time
point were ﬁxed in methanol and paraﬃne m b e d d e d .5μm
transverse sections were stained with hematoxylin and eosin.
Sections were viewed on an Olympus BX51 microscope
(Olympus; Center Valley, PA). The depth below the scaﬀold
edge was measured using an objective micrometer (Olym-
pus). Sections representing the periphery (top third and
bottom third) and core (middle third) of the scaﬀold were
reviewed. The number of cells per 4× low-power ﬁeld (LPF)
was counted (3 nonconsecutive sections for each region at
each time point) by two blinded investigators.
2.7. Cellular Activity. An MTT (3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) assay was used
(Sigma) to measure cellular activity in the scaﬀolds. In this
assay, the conversion of yellow MTT to a purple formazan
crystal by viable, metabolically active cells is measured using
spectrophotometry. Scaﬀolds were harvested from static
and ﬂow-perfusion culture at 1, 2, and 6 days, washed in
phosphate-buﬀered saline (PBS), and homogenized. Each
homogenate was subjected to 6mL of 0.5mg/mL MTT (in
PBS) solution and allowed to incubate for 4 hours at 37◦C.
Excess MTT solution was then decanted and 5mL of extrac-
tion solution (5mL isopranolol containing 0.01 N HCl) was
added to the homogenate and allowed to incubate at 20
minutes at 37◦C. 100μL aliquots of the resulting supernatant
were then added to a 96-well plate and the absorbance
at 570nm was determined using spectrophotometry. Cell
activity was then expressed as the absorbance at 570nm per
gram of scaﬀold.
2.8. Statistical Analysis. A l ld a t aa r ee x p r e s s e da sm e a n±
standard error of the mean. Data were analyzed with a
two-tailed Student’s t-test assuming unequal variance using
SigmaStat(SPSSScience;Chicago,IL).ValuesofP<. 05were
considered signiﬁcant.
3. Results
3.1. Cells Are Distributed Uniformly after Seeding. Scaﬀolds
harvested 12 hours after seeding demonstrated a homoge-
nous distribution of cells in pores throughout the scaﬀold
(Figure 2). At this early time point, cell density in the periph-
ery(109.3±5.5cells/LPF)andcore(106.8±3.9cells/LPF)was
not signiﬁcantly diﬀerent (P = .67).
3.2. Cusp of Viability in Static Culture Is 4 Days. Scaﬀolds
in static culture had a slow, but signiﬁcant decline in the
peripheral cell density over the course of the experiment
(Figure 3). Compared to the initial seeding density (109.3 ±
5.5cells/LPF), there were 106.7 ± 2.0cells/LPF (97.6% of the4 Journal of Biomedicine and Biotechnology
Figure 2: Photomicrograph (100×) highlighting the uniform cell
distribution within the scaﬀold. All pores throughout the scaﬀolds
have a similar appearance 12 hours after seeding.
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Figure 3: Static cultured scaﬀolds had a 34% reduction in cellular
viability at the periphery over the experimental period. In contrast,
dynamic culture resulted in an 8.3% decrease in cell viability.
initially seeded cells) at day 2 (P = .4), 82.3 ± 3.8cells/LPF
(75.2%) at day 4 (P = .003), 76.3 ± 5.2cells/LPF (69.8%)
at day 6 (P = .004), and 72.3 ± 1.2cells/LPF (66.1%) at day
8( P = .001). Cell density in the periphery was similar to a
depth of approximately 2mm from the superior and inferior
surface of the scaﬀold. There was no statistical diﬀerence in
cell density between superior and inferior portions of the
periphery at any time point (data not shown).
In marked contrast to the peripheral crust (outer 2mm)
of the scaﬀold, the core (central 2mm) of these same scaf-
folds exhibited a rapid decline in cell density (Figure 4(a)).
Within the core, cell density was 70.3 ± 5.5cells/LPF (64.3%
remaining of the initially seeded cells) at day 2 (P = .003),
39.0 ± 4.4 (35.7%) at day 4 (P = .001), 4.67 ± 1.8 (4.2%) at
day 6 (P<. 001), and 0.25 ± 0.25 (0.2%) at day 8 (P<. 001).
The cusp of viability for cells in the core was day 4; between
days 4 and 6, there was a dramatic 88% reduction (P = .002)
in cell density (Figure 4(b)).
The metabolic activity of cells in static culture also
declined over the course of the experiment (Figure 5).
MTT cell assay demonstrated that cellular activity in
scaﬀolds in static culture declined to 74% of initial activity
(0.39 ± 0.04OD/g) at day 2 and 70% of initial activity
(0.37 ± 0.04OD/g) at day 6. The change in metabolic
activity was signiﬁcant by day 6 (P = .025). In static culture,
metabolically active cells were limited to the periphery of the
scaﬀold.
3.3. Flow-Perfusion Culture Promotes Cellular Viability
in the Scaﬀold Core. Similar to static culture, scaﬀolds
placed in ﬂow-perfusion had a peripheral cell density of
108.0 ± 5.9cells/LPF (98.9% of the initially seeded cells) at
day 2, 99.3 ± 6.1 (90.9%) at day 4, 92.7 ± 1.8 (84.9%) at
day 6, and 100.0 ± 1.5 (91.5%) at day 8 (Figure 3). Pairwise
comparisons demonstrated a signiﬁcantly greater number
of cells in the periphery of scaﬀolds placed in ﬂow-perfusion
on days 6 (P = .04) and 8 (P = .0001). Similar to static
culture samples, there was no diﬀerence in cellular density
between the inferior and superior thirds of the scaﬀold (data
not shown).
In marked contrast to static culture, scaﬀolds placed in
ﬂow-perfusion maintained signiﬁcantly higher cell density
within the core of the scaﬀold (Figures 6(a) and 6(b)).
Core cell density was 103.7 ± 2.3cells/LPF (94.9% of the
initially seeded cells) at day 2, 80 ± 5.5cells/LPF (73.2%)
at day 4, 83.5 ± 1.5cells/LPF (76.4%) at day 6, and 81.7 ±
6.4cells/LPF (74.7%) at day 8 (Figure 4(a)). The diﬀerences
in core cell density between static and ﬂow-perfusion culture
were statistically signiﬁcant at days 2 (P = .01), 4 (P<. 001),
6( P = .006), and 8 (P = .002).
The metabolic activity of cells in ﬂow-perfusion culture
signiﬁcantly increased over the course of the experiment
(Figure 5).MTTcellassaydemonstratedthatcellularactivity
in scaﬀolds in dynamic culture increased 125% (0.66 ±
0.03OD/g) at day 2 and 285% (0.37 ± 0.04OD/g) at day 6
compared to the initial activity. The increase in metabolic
activity in ﬂow-perfusion was not only signiﬁcantly greater
than the initial activity (day 2, P = .035; day 6, P =
.018), but it was also signiﬁcantly greater than the activity
in static culture at similar time (day 2, P = .002; day 6,
P = .006).
3.4. Core :Periphery Ratio Is Maintained in Flow-Perfusion
Culture. To account for the possibility of confounding shear
stress (despite subthreshold mechanotransductive ﬂow) or
diﬀerences in cell distribution in static versus dynamic cul-
ture, the core:periphery ratio was calculated (Figure 6(c)).
In static culture, the ratio was 0.66±0.05 at day 2, 0.48±0.07
at day 4, 0.06 ± 0.02 at day 6, and 0.004 ± 0.004 at day 8. In
contrast,ﬂowperfusionmaintainedthecore:peripheryratio
to 0.97±0.07 at day 2, 0.82±0.10 at day 4, 0.61±0.30 at day
6, and 0.81±0.07 at day 8. The diﬀerences in core:periphery
ratio of static versus dynamic were statistically signiﬁcant:
day 2 (P = .004), day 4 (P = .005), day 6 (P = .01), and
day 8 (P = .004).Journal of Biomedicine and Biotechnology 5
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Figure 4: (a) Cell density in the core exhibited a rapid decline in
scaﬀolds cultured in static conditions. In contrast, core cell density
was maintained in scaﬀolds treated with ﬂow-perfusion culture. (b)
Photomicrograph of MC3T3-E1 cells in the core of a polyurethane
scaﬀold in static culture. The cusp of viability for cells in the core
lies between day 4 and day 6 for samples in static culture. Between
these time points, there was an 88% reduction in cell density.
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Figure 5: Cellular activity in static and ﬂow-perfusion culture.
MTT assay demonstrates no signiﬁcant change in static culture at
day 2. However, metabolic activity increased signiﬁcantly in cells in
ﬂow-perfusion at days 2 and 6. Metabolic activity also signiﬁcantly
decreased in static culture at day 6.
4. Discussion
The ability to maintain cell viability in vitro in thick 3D
scaﬀolds has important implications for tissue engineering.
For example, attempts at 3D in vitro bone culture without
adequate chemotransportation have invariably shown an
inverse relationship between construct thickness and cellular
survival [2, 12]. This inverse relationship is due to a decline
in nutrients and accumulation of waste products in the
core of the construct during bone matrix deposition and
mineralization.
Traditional cell-culture methods are not well suited to
the maintenance of 3D tissue-engineered constructs due to
theinherentlimitationinchemotransportation.Inourstudy,
we demonstrated that, under static culture conditions, cells
in the peripheral crust up to 2mm deep from the external
s u r f a c ew e r ea b l et os u r v i v eb ys t a t i cd i ﬀusion, a ﬁnding that
is in agreement with other published accounts describing
survival to a depth of 1-2mm [3, 13]. However, we noted a
linear decline in core cell density over time, with less than
5% of cells remaining after 6 days of static culture. These
observedtemporospatialdiﬀerencesincelldensitywithstatic
culture may be explained by two phenomena associated with
poor nutrient diﬀusion: (1) death of cells in the interior core
of the scaﬀold, and (2) chemotaxis of cells from the core
toward the periphery [14].
In an eﬀort to support 3D tissue-engineered constructs,
various bioreactor systems have been designed, including
the spinner ﬂask and the rotational bioreactor. However,
because these designs simply move ﬂuid across the exterior
of the scaﬀold, chemotransportation to the interior is not
guaranteed. The ﬂow-perfusion bioreactor diﬀers in that it
ensures nutrient transport by perfusing medium through
the interconnected pores of the scaﬀold [11]. Moreover, the
design allows the investigator to control mechanical forces;
the pump speed may be set from 3.5 to 200 revolutions
per minute for perfusion ranging from 0.26 to 14.8mls/min,
replicating shear stress from 0.01–10dynes/cm2-physiologic
in vivo range for osteocytes (8–30dynes/cm2)[ 4].
We found that dynamic culture using a ﬂow perfusion
bioreactor signiﬁcantly improved core cell activity and
density compared to static culture. After a slight initial
decrease in cell density between days 2 and 4, core cell
density in ﬂow perfusion was maintained throughout the
course of the experiment at approximately 80% of the initial
seeding density. Likewise, the core:periphery ratio, which
compensates for diﬀerences in cell distribution and potential
eﬀects of ﬂuid shear stress between culture systems, was
steady (approximately 0.6–0.8) from day 2 to day 8.
While originally designed to improve chemotransporta-
tion, the ﬂow-perfusion bioreactor has the ability to generate
ﬂuid-shear forces at the cellular level at higher rates of
medium ﬂow [15]. Although ﬂuid shear forces were inten-
tionally kept subphysiologic (i.e., less than 8 dynes/cm2), to
reduce/eliminate the eﬀects mechanical stimulation during
this study (to concentrate on the eﬀect of chemotransporta-
tion, and not mechanical stimulation), other studies have
suggested that ﬂuid shear forces may be useful for bone or
vascular tissue engineering [11, 16, 17].6 Journal of Biomedicine and Biotechnology
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Figure 6:(a)Dividingthescaﬀoldintothirds,thecoreofstaticculturedscaﬀolds was nearly void ofcells by day 4. Celldensitywas preserved
in the peripheral crust (superior and inferior thirds). (b) Scaﬀolds exposed to ﬂow-perfusion culture exhibit a near homogenous cell density
in all areas of the scaﬀold, with evident cell viability in the core, in contrast to the static cultured samples. (c) To account for the possibility
of confounding shear stress or diﬀerences in cell proliferation in dynamic versus static culture, the core : periphery ratio was calculated.
5. Conclusions
Ultimately, in order to solve clinical problems, engineered
bony tissue must be fashioned into 3D patient-speciﬁc sizes
and shapes. Custom-printed scaﬀolds (e.g., those designed
from actual patient computed tomography data) are too
thick to survive by nonpenetrating chemotransportation.
However,theﬂow-perfusionbioreactorisintheoryascalable
technology that should support porous scaﬀolds of any
thickness. This study demonstrates that thick (>6mm) 3D
constructs are sustainable using a ﬂow-perfusion bioreactor.
Future work will concentrate on computational modeling
of the ﬂuid dynamics and mass transport using speciﬁc
scaﬀold designs, and on analysis of cellular proliferation,
diﬀerentiation, and organization within the construct.
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